The overall objective of the proposed research is to gain insight into marijuana's actions on brain rewards circuits and on dopaminergic and enkephalinergic mechanisms involved in direct brain reward. This work derives from the hypothesis that drugs of abuse, including marijuana, derive part of their abuse liability from neuropharmacological sensitization of brain reward circuits, and is a direct outgrowth of previous work on drug action on brain reward circuits carried out in the applicants' laboratories.
The specific aims are (1) to study the effects of delta-9-tetrahydrocannabinol (Delta9-THC), the major psychoactive ingredient in marijuana, and selected analogs on direct brain reward as measured by the electrical intracranial self-stimulation paradigm in laboratory rats; (2) to study possible neuroanatomic specificity of such effects by directly comparing the effects of Delta9-THC and selected analogs on mesostriatal and mesolimbic brain reward mechanisms; (3) to test for naloxone-reversibility or attenuation of such effects, by analogy to other well-characterized drugs of abuse; (4) to study the effects of Delta9-THC and its analogs on dopamine release, in mesostriatal and mesolimbic forebrain dopaminergic loci associated with direct brain reward, as measured by in vivo electrochemical determination of neurotransmitter release; and (5) to study the effects of Delta9-THC and its analogs on enkephalinergic (delta) receptor density, affinity, and conformation as measured by receptor binding studies and light microscopy autoradiography. By adding to the understanding of marijuana's effects on one of the presumptive neuropharmacologic substrates of drug abuse liability, these studies may well give insight into fundamental brain mechanisms underlying marijuana's abuse potential, and to treatment possibilities for marijuana abuse. The health relatedness of such studies seems clear, given that marijuana is the most widely used illicit drug in the United States, and given the evidence for health consequences of chronic marijuana abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003622-02
Application #
3208159
Study Section
(BPNA)
Project Start
1984-04-01
Project End
1987-08-31
Budget Start
1985-04-01
Budget End
1986-08-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Gardner, Eliot L (2002) Addictive potential of cannabinoids: the underlying neurobiology. Chem Phys Lipids 121:267-90
Gardner, E L; Vorel, S R (1998) Cannabinoid transmission and reward-related events. Neurobiol Dis 5:502-33
Minabe, Y; Gardner, E L; Ashby Jr, C R (1998) Differential effects of chronic haloperidol administration on midbrain dopamine neurons in Sprague-Dawley, Fischer 344, and Lewis rats: an in vivo electrophysiological study. Synapse 29:269-71
Gifford, A N; Gardner, E L; Ashby Jr, C R (1997) The effect of intravenous administration of delta-9-tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo in anesthetized rats. Neuropsychobiology 36:96-9
Chen, J; Marmur, R; Paredes, W et al. (1996) Systemic cocaine challenge after chronic cocaine treatment reveals sensitization of extracellular dopamine levels in nucleus accumbens but direct cocaine perfusion into nucleus accumbens does not: implications for the neural locus of cocaine sensitization Life Sci 58:PL139-46
Lepore, M; Liu, X; Savage, V et al. (1996) Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci 58:PL365-72
Lepore, M; Vorel, S R; Lowinson, J et al. (1995) Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci 56:2073-80
Gardner, E L; Chen, J; Paredes, W (1993) Overview of chemical sampling techniques. J Neurosci Methods 48:173-97
Chen, J; Marmur, R; Pulles, A et al. (1993) Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient. Brain Res 621:65-70
Gardner, E L; Lowinson, J H (1991) Marijuana's interaction with brain reward systems: update 1991. Pharmacol Biochem Behav 40:571-80

Showing the most recent 10 out of 16 publications